Please select an option below to help us tailor your newsletter to best suit your content interests!
Dr. Gregory Vidal was recently featured by the American Society of Clinical Oncology (ASCO), highlighting the critical role federal funding plays in advancing cancer research. As both a medical oncologist and clinical researcher, Dr. Vidal sees firsthand how continued investment in research helps fuel new discoveries, expand access to innovative treatments, and ensure tomorrow’s breakthroughs… Read more »
In a new article highlighting the importance of inclusive clinical research, we have been recognized as 1 of the 4 inaugural sites of Genentech‘s Advancing Inclusive Research® (AIR) Site Alliance. The article highlights how our research team identified an eligibility requirement in a breast cancer study that was disproportionately excluding Black women. Our team’s feedback helped… Read more »
In the News We’re proud to share that Dr. Gregory Vidal was recently featured in DocWire News. In this article, “Exploring the evERA BC Trial With Dr. Gregory Vidal: Improving Endocrine Response Beyond CDK4/6 Resistance,” Dr. Vidal discusses findings presented at ESMO 2025 from the phase 3 evERA BC trial—which investigated giredestrant plus everolimus in… Read more »
Dr. Gregory Vidal is taking part in the Summit on Cancer Health Disparities 2025 — a national conference focused on finding real solutions to reduce cancer health disparities across all communities. Dr. Vidal will serve as both a Planning Committee Member and Co-Chair of the Abstract Committee, helping lead conversations that will shape the future of… Read more »
This past Thursday, Total Health Conferencing hosted a conference for Updates in GI and Breast Cancers. This educational event gathered oncologists, pharmacists, advanced practitioners, and nurses to focus on the latest advancements in GI cancer and breast cancer care. Thank you to our very own Dr. Axel Grothey and Dr. Gregory Vidal for serving as… Read more »
HEALTHCARE HEROES We are so proud of Dr. Gregory Vidal and Parrish Throckmorton, PT for being nominated as Memphis Business Journal’s healthcare heroes! With 5 nominees in only 5 categories – our West family is elated to have 2 team members recognized for their efforts and relentless pursuit of excellence in healthcare, making them true… Read more »
Dr. Gregory Vidal is co-leading a groundbreaking study aimed at identifying barriers to health care for Black women in the Mid-South. This initiative, supported by a $1.58 million grant from Gilead Sciences, Inc., is a collaborative effort with Dr. Janeane Anderson from the University of Tennessee Health Science Center’s College of Nursing. This research seeks… Read more »
West Cancer Center & Research Institute proudly announces that two of their oncology providers, Dr. Michael Berry, Breast Oncology Surgeon and Dr. Gregory Vidal, Medical Oncologist and Director of Clinical Research recently visited Capitol Hill in Washington, DC. They engaged with lawmakers from across the state and political spectrum to address crucial issues affecting cancer… Read more »
🏆 20 West physicians have been named Castle Connolly Top Doctors 🏆 Castle Connolly’s Top Docs represent the ✨top 7%✨ of all U.S. practicing physicians! Selected through a rigorous process of peer nominations and thorough vetting by a physician-led research team, these doctors are truly top-notch healthcare providers. Their exceptional clinical care, specialty expertise, and… Read more »
An abstract created in partnership with Dr. Gregory Vidal and Dr. Andrea Curry of our West family about Addressing Breast Cancer Disparities has been officially accepted by San Antonio Breast Cancer Symposium Alongside Rabble Health and the Urban Health Education & Support Services, this team will present methods used to measurably address social determinants of… Read more »